Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117840452 | 11784045 | 2 | F | 20080620 | 20160819 | 20151128 | 20160819 | EXP | ZA-BRISTOL-MYERS SQUIBB COMPANY-14198980 | BRISTOL MYERS SQUIBB | 30.29 | YR | F | Y | 0.00000 | 20160819 | CN | RU | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117840452 | 11784045 | 1 | PS | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE | 1 | Oral | 400 MG, QD | Y | 21567 | 400 | MG | CAPSULE, HARD | QD | |||||
| 117840452 | 11784045 | 2 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | 100 MG, QD | Y | 0 | 100 | MG | QD | ||||||
| 117840452 | 11784045 | 3 | C | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Oral | 1 DF, QD | Y | 0 | 1 | DF | QD | ||||||
| 117840452 | 11784045 | 4 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | Unknown | UNK | U | 0 | |||||||||
| 117840452 | 11784045 | 5 | C | FOLIC ACID. | FOLIC ACID | 1 | Unknown | UNK | U | 0 | |||||||||
| 117840452 | 11784045 | 6 | C | VITAMIN C | ASCORBIC ACID | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117840452 | 11784045 | 1 | HIV infection |
| 117840452 | 11784045 | 2 | HIV infection |
| 117840452 | 11784045 | 3 | HIV infection |
| 117840452 | 11784045 | 4 | Product used for unknown indication |
| 117840452 | 11784045 | 5 | Product used for unknown indication |
| 117840452 | 11784045 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117840452 | 11784045 | OT |
| 117840452 | 11784045 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117840452 | 11784045 | Caesarean section | |
| 117840452 | 11784045 | Eclampsia | |
| 117840452 | 11784045 | Live birth | |
| 117840452 | 11784045 | Maternal exposure during pregnancy | |
| 117840452 | 11784045 | Pneumonia | |
| 117840452 | 11784045 | Pre-eclampsia | |
| 117840452 | 11784045 | Premature delivery | |
| 117840452 | 11784045 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117840452 | 11784045 | 1 | 20080416 | 20080620 | 0 | |
| 117840452 | 11784045 | 2 | 20080416 | 20080620 | 0 | |
| 117840452 | 11784045 | 3 | 20080416 | 20080620 | 0 | |
| 117840452 | 11784045 | 4 | 20080118 | 0 | ||
| 117840452 | 11784045 | 5 | 20080118 | 0 | ||
| 117840452 | 11784045 | 6 | 20080118 | 0 |